Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Aspira Women's Health Inc AWH

Aspira Women's Health Inc. is engaged in the discovery, development, and commercialization of noninvasive, artificial intelligence (AI)-powered tests to aid in the diagnosis of gynecologic diseases. The Company's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their... see more

Bullboard (NDAQ:AWH)

View:
Post by whytestockson Apr 09, 2024 11:30am

Aspira Women's Health Announces Anthem Blue Cross to Provide

Breaking News: $AWH Aspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in CaliforniaAUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women@s Health Inc. ...more  
Post by AviseAnalyticson Feb 02, 2024 8:02am

ASPIRA WOMEN’S HEALTH: IMPROVING OVARIAN CANCER DETECTION

$AWH   Excited to share an article about Aspira Women’s Health Inc (Nasdaq: AWH), a bio-analytical-based women's health company focused on developing gynecologic disease diagnostic ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities